Active Ingredient (In Each 10 Ml)
Guaifenesin, USP 200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Raritan Pharmaceuticals Inc for the product Drx Choice (NDC 68163-743). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each 10 ml), purpose, use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin, USP 200 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away at (1-800-222-1222).
age | dose |
adults and children 12 years and over | 10 – 20 mL every 4 hours |
children under 12 years | do not use |
anhydrous citric acid, disodium edetate, FD&C red no. 40, flavor, potassium citrate, propylene glycol, purified water, sodium benzoate, sorbitol, sucralose, xanthan gum.
DRx CHOICE®
NDC# 68163-743-04
Compare to the active ingredient in Robitussin® Mucus + Chest Congestion*
Adult Cough Syrup
Guaifenesin (Expectorant)
Relieves:
Sugar-Free
ORIGINAL
Fruit Punch Flavor
Naturally and Artificially Flavored
For Ages 12 & Over
4 FL OZ (118 mL)
IMPORTANT: Keep this carton for future reference on full labeling. |
*This product is not manufactured or distributed by Pfizer, owner of the registered trademark Robitussin® Mucus + Chest Congestion.
Manufactured by:
Raritan Pharmaceuticals
8 Joanna Court,
East Brunswick, NJ 08816
* Please review the disclaimer below.